Fintel reports that on June 3, 2025, JMP Securities downgraded their outlook for Blueprint Medicines (NasdaqGS:BPMC) from ...

Fintel reports that on June 2, 2025, JMP Securities initiated coverage of Aspen Insurance Holdings (NYSE:AHL) with a Market ...

On May 29, JMP Securities Silvan Tuerkcan revised the firm’s view on Taysha Gene Therapies, Inc. (NASDAQ: TSHA ), raising the ...

Analysts at JMP Securities remain optimistic about Caesars Entertainment, Inc. (NASDAQ:CZR), restating their Market ...

JMP Securities analyst Patrick Walravens reiterated a “Market Outperform” rating on SAP SE (NYSE:SAP) with a steady $330 ...

On Tuesday, May 20, JMP Securities analysts reiterated a “Market Outperform” for Snowflake Inc. (NYSE:SNOW) and kept a price target of $201. This decision comes as the company is set to announce its ...

On Tuesday, May 20, JMP Securities analysts reiterated a “Market Outperform” for Snowflake Inc. (NYSE:SNOW) and kept a price target of $201. This decision comes as the company is set to ...

We recently published a list of 11 AI Stocks On Wall Street’s Radar. In this article, we are going to take a look at where Salesforce Inc. (NYSE:CRM) stands against other AI stocks on Wall Street’s ...

On Tuesday, JMP Securities adjusted its outlook on Prime Medicine (NASDAQ: PRME), reducing the price target from the previous $10.00 to $6.00, while retaining a Market Outperform rating for the ...

On Monday, Salesforce.com Inc (NYSE:CRM) maintained its Market Outperform rating and $430.00 price target from JMP Securities. The affirmation comes after Salesforce introduced new flexible pricing ...